A study in healthy Japanese men to test how different doses of BI 690517 are taken up in the body and how well they are tolerated
Phase 1
Completed
- Conditions
- -
- Registration Number
- JPRN-jRCT2080224000
- Lead Sponsor
- ippon boehringer ingelheim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 36
Inclusion Criteria
Healthy male Japanese subjects, age of 20 to 50 years, body mass index (BMI) of 18.5
to 25.0 kg/m2
Exclusion Criteria
1. Any finding in the medical examination (including BP, PR or ECG) is deviating from
normal and judged as clinically relevant by the investigator
2. Repeated measurement of systolic blood pressure outside the range of 100 to 140 mmHg,
diastolic blood pressure outside the range of 50 to 90 mmHg, or pulse rate outside the
range of 50 to 90 bpm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>safety, tolerability, pharmacokinetics
- Secondary Outcome Measures
Name Time Method safety<br>pharmacokinetics<br>safety, tolerability, pharmacokinetics